Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance

Diabetes. 2011 Oct;60(10):2474-83. doi: 10.2337/db11-0194. Epub 2011 Sep 12.

Abstract

Objective: Tissue inflammation is a key factor underlying insulin resistance in established obesity. Several models of immuno-compromised mice are protected from obesity-induced insulin resistance. However, it is unanswered whether inflammation triggers systemic insulin resistance or vice versa in obesity. The purpose of this study was to assess these questions.

Research design and methods: We fed a high-fat diet (HFD) to wild-type mice and three different immuno-compromised mouse models (lymphocyte-deficient Rag1 knockout, macrophage-depleted, and hematopoietic cell-specific Jun NH(2)-terminal kinase-deficient mice) and measured the time course of changes in macrophage content, inflammatory markers, and lipid accumulation in adipose tissue, liver, and skeletal muscle along with systemic insulin sensitivity.

Results: In wild-type mice, body weight and adipose tissue mass, as well as insulin resistance, were clearly increased by 3 days of HFD. Concurrently, in the short-term HFD period inflammation was selectively elevated in adipose tissue. Interestingly, however, all three immuno-compromised mouse models were not protected from insulin resistance induced by the short-term HFD. On the other hand, lipid content was markedly increased in liver and skeletal muscle at day 3 of HFD.

Conclusions: These data suggest that the initial stage of HFD-induced insulin resistance is independent of inflammation, whereas the more chronic state of insulin resistance in established obesity is largely mediated by macrophage-induced proinflammatory actions. The early-onset insulin resistance during HFD feeding is more likely related to acute tissue lipid overload.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism
  • Animals
  • Blood Glucose
  • Ceramides / metabolism
  • Dietary Fats / administration & dosage*
  • Dietary Fats / adverse effects*
  • Drug Administration Schedule
  • Epididymis / metabolism
  • Glucose / metabolism
  • Glucose Tolerance Test
  • Inflammation / chemically induced*
  • Inflammation / metabolism*
  • Insulin Resistance / physiology*
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal / metabolism

Substances

  • Blood Glucose
  • Ceramides
  • Dietary Fats
  • Glucose